Oncogenic epigenetic factor EP300 is a potential therapeutic target for bladder carcinoma
Fields of Study & Subjects
Bladder and Urothelial Cancer Treatments
Epigenetics and DNA Methylation
Chromatin Remodeling and Cancer
Publication details
- Journal / source
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Volume
- 1872
- Issue
- 4
- Pages
- 168182–168182
- Publication date
- 6 February 2026
- Language
- EN